Incidence of SARS-CoV-2 in people with cystic fibrosis in Europe between February and June 2020

Dorjee, 2020, Prevalence and predictors of death and severe disease in patients hospitalized due to COVID-19: A comprehensive systematic review and meta-analysis of 77 studies and 38,000 patients, PLoS One, 15, 10.1371/journal.pone.0243191 Kiedrowski, 2018, Viral-Bacterial Co-infections in the Cystic Fibrosis Respiratory Tract, Front Immunol, 9, 3067, 10.3389/fimmu.2018.03067 Viviani, 2011, Impact of the A (H1N1) pandemic influenza (season 2009-2010) on patients with cystic fibrosis, J Cyst Fibros, 10, 370, 10.1016/j.jcf.2011.06.004 Pinar Senkalfa, 2020, Effect of the COVID-19 pandemic on anxiety among children with cystic fibrosis and their mothers, Pediatr Pulmonol, 55, 2128, 10.1002/ppul.24900 Corvol, 2020, First Wave of COVID-19 in French Patients with Cystic Fibrosis, J Clin Med, 9, 3624, 10.3390/jcm9113624 Cosgriff, 2020, A multinational report to characterise SARS-CoV-2 infection in people with cystic fibrosis, J Cyst Fibros, 19, 355, 10.1016/j.jcf.2020.04.012 McClenaghan, 2020, The global impact of SARS-CoV-2 in 181 people with cystic fibrosis, J Cyst Fibros, 19, 868, 10.1016/j.jcf.2020.10.003 Bain, 2021, Clinical characteristics of SARS-CoV-2 infection in children with cystic fibrosis: An international observational study, J Cyst Fibros, 20, 25, 10.1016/j.jcf.2020.11.021 World Health Organization. Public health surveillance for COVID-19.2020. https://www.who.int/publications/i/item/who-2019-nCoV-surveillanceguidance-2020. 7 Date accessed: 23 November 2020. World Health Organization. Laboratory testing for 2019 novel coronavirus (2019-nCoV) in suspected human cases.2020. https://www.who.int/publications/i/item/10665-331501. Date accessed: 23 November 2020. World Health Organization. International guidelines for certification and classification (coding) of Covid-19 as cause of death.2020. https://www.who.int/classifications/icd/Guidelines_Cause_of_Death_COVID-19.pdf?ua=1. Date accessed: 23 November 2020. ZolinA, OrentiA, NaehrlichL, JungA, van RensJ. ECFS Patient Registry Annual Report 2018. 2020. https://www.ecfs.eu/projects/ecfs-patient-registry/annual-reports Viviani, 2014, The European Cystic Fibrosis Society Patient Registry: valuable lessons learned on how to sustain a disease registry, Orphanet J Rare Dis, 9, 81, 10.1186/1750-1172-9-81 Dataset. European Centre for Disease Control.Daily number of new reported cases of COVID-19 by country worldwide.2020. https://www.ecdc.europa.eu/en/publications-data/download-todays-data-geographic-distribution-covid-19-cases-worldwide. Date accessed: 06 Dec 2020. Dataset. European Centre for Disease Control.Data on hospital and ICU admission rates and current occupancy for COVID-19.2020. https://www.ecdc.europa.eu/en/publications-data/download-data-hospital-and-icu-admission-rates-and-current-occupancy-covid-19. Date accessed: 06 Dec 2020. European Centre for Disease Control. How ECDC collects and processes Covid-19 data. 2021. https://www.ecdc.europa.eu/en/covid-19/data-collection. Date accessed: 11 Jan 2021. Quanjer, 2012, Multi-ethnic reference values for spirometry for the 3-95-yr age range: the global lung function 2012 equations, Eur Respir J, 40, 1324, 10.1183/09031936.00080312 EngelsB. XNomial: Exact Goodness-of-Fit Test for Multinomial Data with Fixed Probabilities. R package version 1.0.4 2015. https://cran.r-project.org/package=XNomial Mondejar-Lopez, 2020, Impact of SARS-CoV-2 infection in patients with cystic fibrosis in Spain: Incidence and results of the national CF-COVID19-Spain survey, Respir Med, 170, 10.1016/j.rmed.2020.106062 Padoan, 2021, First and second wave of SARS-CoV2 in Italian Cystic Fibrosis patients: Data from Italian Cystic Fibrosis Registry, J Cyst Fibros, 26, S1569 Bezzerri, 2020, Does cystic fibrosis constitute an advantage in COVID-19 infection?, Ital J Pediatr, 46, 143, 10.1186/s13052-020-00909-1 Stephenson, 2017, The changing epidemiology and demography of cystic fibrosis, Presse Med, 46, e87, 10.1016/j.lpm.2017.04.012 Dataset. European Centre for Disease Control.Data on testing for COVID-19 by week and country.2020. https://www.ecdc.europa.eu/en/publications-data/covid-19-testing. van Koningsbruggen-Rietschel, 2020, SARS-CoV-2 disrupts clinical research: the role of a rare disease-specific trial network, Eur Respir J, 56, 10.1183/13993003.02114-2020 Colombo, 2020, Impact of COVID-19 on people with cystic fibrosis, Lancet Respir Med, 8, e35, 10.1016/S2213-2600(20)30177-6 van Kasteren, 2020, Comparison of seven commercial RT-PCR diagnostic kits for COVID-19, J Clin Virol, 128, 10.1016/j.jcv.2020.104412 Buitrago-Garcia, 2020, Occurrence and transmission potential of asymptomatic and presymptomatic SARS-CoV-2 infections: A living systematic review and meta-analysis, PLoS Med, 17, 10.1371/journal.pmed.1003346 Peckham, 2020, Male sex identified by global COVID-19 meta-analysis as a risk factor for death and ITU admission, Nat Commun, 11, 6317, 10.1038/s41467-020-19741-6 Centers for disease control and prevention (CDC). Evidence used to update the list of underlying medical conditions that increase a person's risk of severe illness from COVID-19. 2020. https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/evidence-table.html. Date accessed: 22 December 2020. Raja, 2021, COVID-19 in solid organ transplant recipients: A systematic review and meta-analysis of current literature, Transplant Rev (Orlando), 35, 10.1016/j.trre.2020.100588 Saez-Gimenez, 2020, COVID-19 in lung transplant recipients: A multicenter study, Am J Transplant Kondratyeva, 2020, COVID-19 in cystic fibrosis patients, Pulmonologiya, 30, 544, 10.18093/0869-0189-2020-30-5-544-552 Dennis, 2020, Influenza B outbreak at an adult cystic fibrosis centre - Clinical impact and factors influencing spread, J Cyst Fibros, 19, 808, 10.1016/j.jcf.2020.04.011